Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health Canada Accepts New Drug Submission for Lecanemab as
TOKYO and CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) --…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lecanemab
Eisai Presented New Analyses of ARIA and QOL on Lecanemab
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) --…
Biologics License Application for Lecanemab Designated for
<!-- Name:DistributionId Value:8777710 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Lecanemab Receives Priority Review Status in Japan
<!-- Name:DistributionId Value:8738427 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Marketing Authorization Application for Lecanemab as
TOKYO and CAMBRIDGE, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A.…